Share
Management of HER2 positive breast cancer
Hayette Sénia Bensaber
(Author)
·
Meriem Benaouda
(Author)
·
Our Knowledge Publishing
· Paperback
Management of HER2 positive breast cancer - Bensaber, Hayette Sénia ; Benaouda, Meriem
Choose the list to add your product or create one New List
✓ Product added successfully to the Wishlist.
Go to My Wishlists
Origin: U.S.A.
(Import costs included in the price)
It will be shipped from our warehouse between
Friday, July 26 and
Friday, August 02.
You will receive it anywhere in United Kingdom between 1 and 3 business days after shipment.
Synopsis "Management of HER2 positive breast cancer"
Despite the evolution of therapeutic management, breast cancer remains one of the most frequent cancers in the world. This therapeutic evolution implies the appearance of new prognostic and predictive factors such as hormone receptors and the HER2 oncogene. Breast cancer tissue can be sensitive to steroid hormones (estrogen and progesterone), and is therefore referred to as hormone-dependent and hormone-sensitive cancer. As one of the most common gene alterations observed in this disease is the amplification of the HER2 oncogene leading to an overexpression of its oncoprotein, a new therapy has been developed. In our retrospective study over a period of three years, we found a stable incidence of breast cancer in the Military Regional University Hospital of Oran HMRUO, we also evaluated the therapeutic management. surgery, including mastectomy, remains the most used treatment just after adjuvant chemotherapy.
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
All books in our catalog are Original.
The book is written in English.
The binding of this edition is Paperback.
✓ Producto agregado correctamente al carro, Ir a Pagar.
